ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04670	Leukocyte transendothelial migration	15/181	151/7206	5.10546036575e-06
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	10/181	79/7206	2.50260375318e-05
ko00512	Mucin type O-glycan biosynthesis	6/181	29/7206	6.78655614569e-05
ko05160	Hepatitis C	13/181	153/7206	0.000114540379805
ko05100	Bacterial invasion of epithelial cells	10/181	99/7206	0.000175374038055
ko04611	Platelet activation	13/181	163/7206	0.000216633681225
ko05133	Pertussis	9/181	87/7206	0.000309861429105
ko05418	Fluid shear stress and atherosclerosis	13/181	173/7206	0.00038864615069
ko04657	IL-17 signaling pathway	8/181	87/7206	0.00146014864183
ko04514	Cell adhesion molecules (CAMs)	10/181	130/7206	0.00153432774464
ko04530	Tight junction	14/181	228/7206	0.00172709208856
ko00363	Bisphenol degradation	2/181	3/7206	0.00185135545102
ko00980	Metabolism of xenobiotics by cytochrome P450	5/181	40/7206	0.00305137818162
ko04668	TNF signaling pathway	9/181	120/7206	0.00311232561834
ko05146	Amoebiasis	8/181	99/7206	0.00331605196566
ko04666	Fc gamma R-mediated phagocytosis	9/181	122/7206	0.00347831700352
ko00511	Other glycan degradation	4/181	26/7206	0.00373448381597
ko05205	Proteoglycans in cancer	15/181	271/7206	0.00416392596118
ko05131	Shigellosis	7/181	82/7206	0.00437140740373
ko00030	Pentose phosphate pathway	4/181	32/7206	0.00799191812179
ko04750	Inflammatory mediator regulation of TRP channels	8/181	122/7206	0.011474192508
ko01524	Platinum drug resistance	6/181	76/7206	0.0118133952211
ko00480	Glutathione metabolism	5/181	55/7206	0.0119313461953
ko04660	T cell receptor signaling pathway	8/181	124/7206	0.012578186551
ko05410	Hypertrophic cardiomyopathy (HCM)	7/181	100/7206	0.0126453250512
ko04210	Apoptosis	10/181	180/7206	0.0150186898667
ko05200	Pathways in cancer	21/181	492/7206	0.0158266844371
ko04621	NOD-like receptor signaling pathway	9/181	157/7206	0.0171234995247
ko04623	Cytosolic DNA-sensing pathway	4/181	41/7206	0.0189089608124
ko04622	RIG-I-like receptor signaling pathway	5/181	62/7206	0.0192988710301
ko04510	Focal adhesion	12/181	240/7206	0.0195010676262
ko00627	Aminobenzoate degradation	2/181	9/7206	0.0201119856853
ko00051	Fructose and mannose metabolism	4/181	42/7206	0.0205005688422
ko05221	Acute myeloid leukemia	5/181	63/7206	0.02054923163
ko04810	Regulation of actin cytoskeleton	13/181	264/7206	0.0239282822148
ko05222	Small cell lung cancer	6/181	89/7206	0.0240869533312
ko00361	Chlorocyclohexane and chlorobenzene degradation	1/181	1/7206	0.0251179572578
ko00540	Lipopolysaccharide biosynthesis	1/181	1/7206	0.0251179572578
ko00364	Fluorobenzoate degradation	1/181	1/7206	0.0251179572578
ko00623	Toluene degradation	1/181	1/7206	0.0251179572578
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/181	92/7206	0.0278095310379
ko04015	Rap1 signaling pathway	13/181	278/7206	0.0287254734899
ko00460	Cyanoamino acid metabolism	2/181	11/7206	0.0297323392142
ko05204	Chemical carcinogenesis	4/181	48/7206	0.0317595793507
ko05034	Alcoholism	1/181	238/7206	0.032033970308
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/181	28/7206	0.0322155320187
ko04064	NF-kappa B signaling pathway	6/181	96/7206	0.0333386802535
ko04912	GnRH signaling pathway	7/181	122/7206	0.0335669443764
ko04624	Toll and Imd signaling pathway	4/181	49/7206	0.033926976442
ko05010	Alzheimer's disease	10/181	202/7206	0.0360750469921
ko05132	Salmonella infection	6/181	98/7206	0.0363528382385
ko00564	Glycerophospholipid metabolism	6/181	99/7206	0.0379235264604
ko05164	Influenza A	9/181	167/7206	0.0380926318224
ko04620	Toll-like receptor signaling pathway	6/181	100/7206	0.0395370286776
ko04011	MAPK signaling pathway - yeast	4/181	53/7206	0.0434408627562
ko05142	Chagas disease (American trypanosomiasis)	7/181	130/7206	0.0449117893068
ko00430	Taurine and hypotaurine metabolism	2/181	14/7206	0.0468373244871
ko04512	ECM-receptor interaction	5/181	79/7206	0.0480018267148
ko00520	Amino sugar and nucleotide sugar metabolism	4/181	55/7206	0.0487053206065